Confluent Medical announces strategic investment in The Electrospinning Company
Confluent Medical Invests in The Electrospinning Company to expand design options utilized in structural heart markets
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 May 21
Confluent Medical Invests in The Electrospinning Company to expand design options utilized in structural heart markets
27 Apr 21
Depression and anxiety in patients after ICD implantation surgery is well documented, but a new study reveals the…
26 Apr 21
One-year data from the clinical trial confirmed the safety and effectiveness of TaurusOne in treating severe aortic stenosis
22 Apr 21
First patient procedure using new shield surface modification was performed at the NYU Langone Health in New York…
22 Apr 21
BioStable Science & Engineering is a cardiovascular device company focused on proprietary valve repair technologies
21 Apr 21
IN.PACT AV is said to be the first and only drug-coated balloon to show sustained and superior effectiveness…
19 Apr 21
Neuroguard IEP system is indicated for adult patients with clinically significant carotid artery stenosis requiring stenting
19 Apr 21
The Deep Learning Spectral CT is designed to enable healthcare providers acquire whole-heart spectral images in one beat
19 Apr 21
Guide catheter extensions are a crucial tool used by cardiologists worldwide to assist in the delivery of stents…
16 Apr 21
The PROTECT IV trial is designed to compare the benefits of HRPCI with Impella compared to HRPCI without…